Literature DB >> 12376617

A nucleolar TAR decoy inhibitor of HIV-1 replication.

Alessandro Michienzi1, Shirley Li, John A Zaia, John J Rossi.   

Abstract

Tat is a critical regulatory factor in HIV-1 gene expression. It mediates the transactivation of transcription from the HIV-1 LTR by binding to the transactivation response (TAR) element in a complex with cyclin T1. Because of its critical and early role in HIV gene expression, Tat and its interaction with the TAR element constitute important therapeutic targets for the treatment of HIV-1 infection. Based on the known nucleolar localization properties of Tat, we constructed a chimeric small nucleolar RNA-TAR decoy that localizes to the nucleoli of human cells and colocalizes in the nucleolus with a Tat-enhanced GFP fusion protein. When the chimeric RNA was stably expressed in human T lymphoblastoid CEM cells it potently inhibited HIV-1 replication. These results demonstrate that the nucleolar trafficking of Tat is critical for HIV-1 replication and suggests a role for the nucleolus in HIV-1 viral replication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376617      PMCID: PMC137834          DOI: 10.1073/pnas.212229599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication.

Authors:  B A Sullenger; H F Gallardo; G E Ungers; E Gilboa
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

2.  A rapid method for the construction of synthetic genes using the polymerase chain reaction.

Authors:  P J Dillon; C A Rosen
Journal:  Biotechniques       Date:  1990-09       Impact factor: 1.993

3.  Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization.

Authors:  H Siomi; H Shida; M Maki; M Hatanaka
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Detection of SIV antigens by HIV-1 antigen capture immunoassays.

Authors:  S Goldstein; R Engle; R A Olmsted; V M Hirsch; P R Johnson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing.

Authors:  H Siomi; H Shida; S H Nam; T Nosaka; M Maki; M Hatanaka
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

6.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.

Authors:  D D Ho; T Moudgil; M Alam
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

7.  Structural and functional characterization of human immunodeficiency virus tat protein.

Authors:  S Ruben; A Perkins; R Purcell; K Joung; R Sia; R Burghoff; W A Haseltine; C A Rosen
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

8.  Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody.

Authors:  D D Ho; J A McKeating; X L Li; T Moudgil; E S Daar; N C Sun; J E Robinson
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation.

Authors:  B A Sullenger; H F Gallardo; G E Ungers; E Gilboa
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  HIV-1 Tat protein promotes formation of more-processive elongation complexes.

Authors:  R A Marciniak; P A Sharp
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  56 in total

Review 1.  The nucleolus.

Authors:  Thoru Pederson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 2.  Functional roles of HIV-1 Tat protein in the nucleus.

Authors:  Yana R Musinova; Eugene V Sheval; Carla Dib; Diego Germini; Yegor S Vassetzky
Journal:  Cell Mol Life Sci       Date:  2015-10-27       Impact factor: 9.261

3.  Toward targeting RNA structure: branched peptides as cell-permeable ligands to TAR RNA.

Authors:  David I Bryson; Wenyu Zhang; Patrick M McLendon; Theresa M Reineke; Webster L Santos
Journal:  ACS Chem Biol       Date:  2011-10-28       Impact factor: 5.100

Review 4.  The moving parts of the nucleolus.

Authors:  M O J Olson; Miroslav Dundr
Journal:  Histochem Cell Biol       Date:  2005-03-02       Impact factor: 4.304

Review 5.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

6.  Molecular recognition of HIV-1 RNAs with branched peptides.

Authors:  Ashley N Peralta; Yumin Dai; Chringma Sherpa; Stuart F J Le Grice; Webster L Santos
Journal:  Methods Enzymol       Date:  2019-05-15       Impact factor: 1.600

7.  Use of a U16 snoRNA-containing ribozyme library to identify ribozyme targets in HIV-1.

Authors:  Hoshang J Unwalla; Haitang Li; Shi-Yang Li; Danny Abad; John J Rossi
Journal:  Mol Ther       Date:  2008-04-01       Impact factor: 11.454

Review 8.  HIV/AIDS: modified stem cells in the spotlight.

Authors:  Enrique Armijo; Claudio Soto; Brian R Davis
Journal:  Cell Mol Life Sci       Date:  2014-02-08       Impact factor: 9.261

9.  Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.

Authors:  Reem Berro; Kylene Kehn; Cynthia de la Fuente; Anne Pumfery; Richard Adair; John Wade; Anamaris M Colberg-Poley; John Hiscott; Fatah Kashanchi
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  A dual function TAR Decoy serves as an anti-HIV siRNA delivery vehicle.

Authors:  Hoshang J Unwalla; John J Rossi
Journal:  Virol J       Date:  2010-02-10       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.